INDAPTUS THERAPEUTICS INC

INDPNASDAQ

🏆 #3644 by market capEarnings Aug 17US Equity

$1.08▼ $0.10 (−9.24%)

Live

1h▲ 0.0%

24h▼ 9.2%

7d▼ 20.0%

14d▼ 43.7%

30d▼ 57.7%

1y▼ 85.8%

🏦Market Cap

$122M

Small Cap

📈Revenue Growth (YoY)

+0.0%

Slowing

📊Gross Margin

0.0%

Thin

💵FCF Margin

0.0%

Thin

⚖️P/S Ratio

0.0x

Cheap

Otter Score

Weak

Trading Snapshot

Day Range: $1.07 – $1.09
52-Week Range: $0.92 – $8.69
Volume: $2.52B
Avg Volume: $2.00B
Shares Outstanding: 113.2M
Next Earnings: Sep 1, 2026

Fundamentals Snapshot

Annual Revenue: $14M
Last Q Revenue: $3M
P/E Ratio: -0.2
P/S Ratio: 0.0x
EPS (TTM): $-8.70
Dividend Yield: 0.00%

Why Investors Own INDP

✓High-growth profile — revenue up +35.1% YoY with expanding US Equity exposure.
✓Healthy economics — 44% gross margin and 17% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$14M▲ +36.1% YoY

Gross Margin (TTM)

43.9%▲ +3.5% YoY

Operating Income (TTM)

$1M▲ +36.1% YoY

Free Cash Flow (TTM)

$2M▲ +36.1% YoY

About INDAPTUS THERAPEUTICS INC

Indaptus Therapeutics, Inc. is a biotechnology company operating in the pre-clinical phase, dedicated to developing a range of immunotherapeutic products for the treatment of both cancer and viral infections. The firm's lead investigational compound, Decoy20, is currently progressing through Phase I clinical trials. This candidate is being evaluated for its capacity to elicit lasting therapeutic responses, either as a standalone agent or in combination with other treatments, for various conditions including lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as infections caused by the hepatitis B virus and human immunodeficiency virus. Initially incorporated in 2021 under the name Intec Parent, Inc., the company officially rebranded to Indaptus Therapeutics, Inc. in August of the same year. Its corporate headquarters are situated in New York, New York.

🦦